Best Healthcare Companies in North Rhine Westphalia, Germany
The 203 best Healthcare companies in North Rhine Westphalia, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Gerresheimer.
Ranked: Best Healthcare companies in North Rhine Westphalia
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | A & M Group GLP bioanalytical and cGMP analytical testing services for drug development | — | — | 278 | Hartmut Fischer Co-Founder | WordPressPleskApple iCloud Mail+21 | Top 10M | — | — |
| 2 | Adler Standalone drug store | — | — | — | Oliver Korsten Founder | — | — | — | — |
| 3 | Adler-Apotheke am Klinikum Standalone pharmacy | — | — | — | Sabine Schoening Owner | SentryApple iCloud MailAmazon Web Services+11 | Top 50M | — | — |
| 4 | Admedicum Patient-focused healthcare company that specializes in patient engagement and access solutions, helping to… | — | — | — | — | WordPressMySQLPHP+18 | Top 50M | — | — |
| 5 | Advanced Defense Technologies Manufacturer of protective equipment and test kits services | — | — | — | Kevin Abu-Majd CEO | — | — | — | — |
| 6 | aerobis fitness Manufacturer of diversified fitness equipments | — | — | — | — | Cart FunctionalityShopifySentry+31 | Top 5M | 5 patents Cable and elastic resistance training equipment for strength and fitness exercises | — |
| 7 | Aircontrols Manufacturer of gas dosing, respiratory therapy or ventilation systems | — | — | — | Volker Sauerbaum CEO | — | — | 11 patents Medical gas mixing, flow measurement, and composition analysis for patient ventilation systems. | — |
| 8 | Alexianer Health system | — | — | 1,124 | — | — | — | — | — |
Top 12 Healthcare companies in North Rhine Westphalia
#1
Seed · Aachen, North Rhine Westphalia · founded 2022$5.8Mraised▾
Developer of organ preservation solutions for use in labs. The company offer solutions like Vivalyx Omnisol a blood-free preservation solution for all organ preservation methods, including cold and warm perfusion as well as static cold storage, with expected beneficial clinical outcomes.
- Apr 2024Seed$5.8M
#2
Acquired · Dusseldorf, North Rhine Westphalia · founded 1864 · 350 employees$457.1Mraised▾
Manufacturer of primary packaging products for medication and drug delivery devices. Company specializes in the production of drug packaging and delivery systems, with basis on glass and plastic packaging solutions for the pharmaceutical, health, well-being, and biotech industries. It offers prefillable syringes and cartridges made of glass or plastic.
#3
Public · Aachen, North Rhine Westphalia · founded 2000 · 51 employees$47.7Mraised▾
Paion is specialised in developing drugs for the hospital-based treatment of central nervous system (CNS) disorders and thrombotic/cardiovascular diseases. Its drug pipeline include Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anaesthetic for anaesthesia (Phase 3) and for procedural sedation (Phase 3); Morphine-6-glucuronide (M6G), a pharmacologically active metabolite of morphine, is suitable for the treatment of post-operative pain (Phase 3); GGF2 (Glial Growth Factor 2) for heart failure (Phase 1). Paion is not actively involved in the development of GGF2 and M6G, but instead benefits from future milestone payments and royalties. GGF2 is developed by Acorda Therapeutics, and M6G is developed by Yichang Humanwell.
- Jul 2017Post IPO$9.2M
- Jun 2016Post IPO$10.6M
- Jul 2014Post IPO$6.7M
- Jul 2014Post IPO$5.4M
#4
Series A · Dortmund, North Rhine Westphalia · founded 2014 · 71 employees$5.2Mraised▾
Provider of dental aligner manufacturing and private label services
- Oct 2022Series A$5.2M
#5
Late Stage · Minden, North Rhine Westphalia · founded 1949 · 1918 employees$52.9Mraised▾
Healthcare systems
#6
Seed · Munster, North Rhine Westphalia · founded 2019 · 11 employees$2.9Mraised▾
Refined Laser Systems: Revolutionizing cancer diagnostics with innovative laser technology. This dynamic biophotonics company develops cutting-edge laser systems for stain-free, section-free tissue diagnostics. Their technology enables rapid, accurate identification of cancer cells directly from thick specimens, eliminating the need for time-consuming traditional methods. This significantly reduces the time required for diagnosis, allowing for faster treatment decisions and improved patient outcomes. The company's solutions are designed to empower surgeons and pathologists, providing clear insights into tissue and cell systems within minutes. Their commitment to innovation and impact drives them to continuously improve their products and services, ultimately aiming to make a meaningful difference in cancer care. The technology is based on coherent Raman scattering microscopy, a label-free imaging technique that provides high-contrast images comparable to traditional H&E staining. The company is dedicated to improving the lives of patients and healthcare professionals alike.
- Jan 2023Seed$2.9M
#7
Series A · Cologne, North Rhine Westphalia · founded 2010 · 14 employees$4.7Mraised▾
Developer of in-vitro diagnostic products for acute and critical care conditions in newborns. The product HypoxE test is used for the early identification of newborns suffering from perinatal asphyxia due to oxygen deficit during birth, the prognosis of hypoxic-ischemic encephalopathy, and brain injuries.
- Mar 2022Series A—
- Jul 2021Series A$4.7M
#8
Funding Raised · Hagen, North Rhine Westphalia · founded 1996$1.5Mraised▾
ZEUS GmbH is a research center focused on applied psychology, environmental, and social research. The company conducts studies and provides expertise on environmental noise, noise pollution, and its impact on human health and well-being. ZEUS GmbH also offers consulting services and collaborates with other organizations to develop innovative solutions for noise assessment and management.
- Jan 2020Grant (prize money)$596K
- Nov 2017Grant (prize money)$191.9K
- Oct 2017Grant (prize money)$748.6K
- Dec 2016Grant (prize money)—
#9
Funding Raised · Dusseldorf, North Rhine Westphalia · founded 2014$980.1Kraised▾
IXP is a research institute specializing in experimental psychophysiology, conducting cutting-edge studies on human perception, cognition, and behavior. The institute's research focuses on developing innovative methods and technologies to improve well-being, performance, and quality of life. IXP's expertise spans a range of areas, including psychological methods, computer vision, and intelligent textile sensor technology.
- Jan 2021Grant (prize money)$742K
- Jan 2016Grant (prize money)$238.1K
#10
Funding Raised · Dortmund, North Rhine Westphalia · founded 2001 · 11 employees$1.4Mraised▾
Chimera Biotec has developed a proprietary immunoassay platform called Imperacer for ultra-sensitive large molecule bioanalysis. The company claims to be the world's leading Immuno-PCR (IPCR) based technology vendor. The company's products include the Imperacer Workstation, Assay Development Kits and maintenance kit. Services offered include assay development, method validation, and bioanalysis.
- Sep 2016Grant (prize money)$225K
- Mar 2016Grant (prize money)$75K
- May 2015Grant (prize money)$918.9K
- Apr 2015Grant (prize money)$226.3K
#11
Funding Raised · Neuss, North Rhine Westphalia · founded 1999 · 201 employees$226.4Kraised▾
Provider of clinical research services for diabetes and obesity studies. The organization conducts pharmacodynamic, pharmacokinetic, biosimilar, safety, and tolerability studies. It also performs bridging studies. The organization offers expertise in developing treatments for diabetes mellitus type 1 and type 2.
- Dec 2021Grant (prize money)$216.4K
- Sep 2012Grant (prize money)$10K
#12
Funding Raised · Dortmund, North Rhine Westphalia · founded 1999 · 61 employees$572.8Kraised▾
Provider of drug discovery services
- Nov 2018Grant (prize money)—
- Feb 2016Grant (prize money)$271.5K
- Jan 2015Grant (prize money)$301.3K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising